-
Price Momentum
CVSA is trading in the middle of its 52-week range and near its 200-day simple moving average.
-
Price change
The price of CVSA shares has decreased $3.33 since the market last closed. This is a 2.75% drop.
-
Closed at $117.80.
The stock has since risen $2.33 in after-hours trading.
Key terms
About CVSA
Covista, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
-
Market cap: $4.01B
A market capitalization between $2 billion and $10 billion places CVSA in the mid-capitalization category.
Key terms
Smart score
Latest CVSA news
No recent press releases are available for CVSA
CVSA Financials
-
Total revenue: $1.79B (1Y), $487.03M (Q3)
Total Revenue increased 12.85% since last year and decreased 3.25% since last quarter.
-
Net income: $232.68M (1Y), $57.98M (Q3)
Net Income increased 70.11% since last year and decreased 23.88% since last quarter.
-
Earnings per share: $6.07 (1Y), $0.73 (Q3)
EPS increased 78.87% since last year and decreased 65.41% since last quarter.
Key terms
CVSA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CVSA Competitors
-
How competitors are chosen
CVSA's competitors are included in the Consumer Services sector and Other Consumer Services group
-
Market cap: $4.01B
A market capitalization between $2 billion and $10 billion places CVSA in the mid-capitalization category.
